[THE CARCINOID SYNDROME (APROPOS OF 7 CASES)].
D005853:Geriatrics; D013006:Growth Hormone; D006801:Humans; D006897:Hydroxyindoleacetic Acid; D007210:Indoleacetic Acids; D008303:Malignant Carcinoid Syndrome; D008750:Methyldopa; D008775:Methylprednisolone; D010910:Pituitary Irradiation; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D012877:Skin Manifestations; D013812:Therapeutics; D014666:Vasomotor System; D015020:Yttrium Isotopes
D013006:Growth Hormone; D006897:Hydroxyindoleacetic Acid; D007210:Indoleacetic Acids; D008750:Methyldopa; D008775:Methylprednisolone; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D015020:Yttrium Isotopes; C030737:indoleacetic acid
GERIATRICS; HYDROXYINDOLEACETIC ACID; INDOLEACETIC ACID; MALIGNANT CARCINOID SYNDROME; METHYLDOPA; METHYLPREDNISOLONE; PITUITARY GLAND IRRADIATION; SEROTONIN INHIBITORS; SKIN MANIFESTATIONS; SOMATOTROPIN; THERAPEUTICS; VASOMOTOR SYSTEM; YTTRIUM ISOTOPES
LE SYNDROME CARCINOUIDIEN (A PROPOS DE SEPT OBSERVATIONS)